Digestive & Intestinal Remedies (Pharmacies) - United Arab Emirates

United Arab Emirates

Highlights

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$45.77m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.03%, resulting in a market volume of US$53.14m by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$4.77 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestive & Intestinal Remedies (Pharmacies) market in United Arab Emirates is experiencing steady growth due to changing customer preferences and market trends.

Customer preferences: Customers in the United Arab Emirates are increasingly seeking digestive and intestinal remedies to address common gastrointestinal issues such as indigestion, bloating, and acid reflux. This can be attributed to changes in dietary habits, stress levels, and overall lifestyle choices. As the population becomes more health-conscious, there is a growing demand for over-the-counter remedies that provide quick relief from digestive discomfort.

Trends in the market: One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in United Arab Emirates is the rising popularity of natural and herbal remedies. Customers are increasingly opting for products that are perceived to be safer and have fewer side effects. This trend is driven by a growing awareness of the potential risks associated with long-term use of conventional medications. As a result, pharmacies are expanding their product offerings to include a wider range of natural remedies, such as herbal teas, probiotics, and dietary supplements. Another trend in the market is the increasing availability of digestive and intestinal remedies in convenient formats. Customers are looking for products that are easy to consume on-the-go, such as chewable tablets, dissolvable powders, and liquid formulations. This trend is driven by the fast-paced lifestyle of urban dwellers in the United Arab Emirates, who often prioritize convenience and efficiency in their healthcare choices.

Local special circumstances: The United Arab Emirates has a high expatriate population, with people from various countries and cultural backgrounds residing in the country. This diversity in the population has led to a demand for digestive and intestinal remedies that cater to different dietary preferences and sensitivities. Pharmacies in the United Arab Emirates are therefore stocking a wide range of products that cater to specific dietary needs, such as gluten-free, lactose-free, and vegan options. This ensures that customers have access to remedies that suit their individual requirements.

Underlying macroeconomic factors: The United Arab Emirates has a strong healthcare infrastructure and a high standard of living, which contributes to the growth of the Digestive & Intestinal Remedies (Pharmacies) market. The country's healthcare system is well-regulated and pharmacies are easily accessible to the general population. Additionally, the United Arab Emirates has a high disposable income per capita, allowing customers to afford over-the-counter remedies for their digestive health needs. The government's focus on promoting a healthy lifestyle and preventive healthcare further drives the demand for digestive and intestinal remedies in the country. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in United Arab Emirates is witnessing growth due to changing customer preferences towards natural and convenient remedies. Pharmacies are adapting to these trends by expanding their product offerings and catering to specific dietary needs. The strong healthcare infrastructure and high disposable income in the country also contribute to the market's development.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.